Philippines Cheaper Medicines Act Signed Into Law
This article was originally published in PharmAsia News
Executive Summary
The president of the Philippines signed into law the Universally Accessible, Cheaper and Quality Medicine Act of 2008, allowing branded drugs to be imported if they are less costly than available drugs. The act also changes the nation's Intellectual Property Code to allow generics makers to produce their versions of patented drugs so they can enter the market as soon as brand-name patents expire. Implementing rules and regulations are not expected to be in place for at least another four months. (Click here for more
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.